Concepedia

Author

A Burlina

University of Padua

Also Known As

A BURLINA, A Burlina, A. B. Burlina, A. Burlina, Alberto Burlina, M. Ugarte

85

Publications

526

Citations

8

H-Index

27

Concepts

All Affiliations

University of PaduaHeidelberg UniversitySapienza University of RomeUniversity Hospital HeidelbergBambino Gesù Children's Hospital
AB

About

A Burlina is an author at University of Padua specializing in medicine, diabetes, and urology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

45

2

Engineering

1

1

22

3

Public Health

1

1

23

4

Biochemistry

1

1

22

5

Diabetes

1

1

23

A Burlina

×

7

Publications

484

Citations

7

H-Index

YearCitations

Clinical Course, Early Diagnosis, Treatment, and Prevention of Disease in Glutaryl-CoA Dehydrogenase Deficiency

G. F. Hoffmann, S. Athanassopoulos, A Burlina,

Neuropediatrics

1996

227

Long-term Follow-up and Outcome of Phenylketonuria Patients on Sapropterin: A Retrospective Study

Stefanie Keil, Karen Anjema, Francjan J. van Spronsen,

PEDIATRICS

2013

79

Clinical and molecular findings in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome

Sergio Salvi, Filippo M. Santorelli, Enrico Bertini,

Neurology

2001

68

Efficacy of ACE‐inhibitor therapy on renal disease in glycogen storage disease type 1: a multicentre retrospective study

Daniela Melis, Giancarlo Parenti, R. Gatti,

Clinical Endocrinology

2005

43

Progression of Renal Damage in Glycogen Storage Disease Type I Is Associated to Hyperlipidemia: A Multicenter Prospective Italian Study

Daniela Melis, Mariarosaria Cozzolino, Giorgia Minopoli,

The Journal of Pediatrics

2015

23

Improved method for fractionating gamma-glutamyltransferase by electrophoresis on cellulose acetate.

A Burlina

Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)

1978

22

Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial

Ania C. Muntau, A Burlina, François Eyskens,

Orphanet Journal of Rare Diseases

2021

22

Page 1